Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niuhuang Qinggan is a Traditional Chinese Medicine (TCM) formulation, typically administered in capsule form, used for the treatment of the common cold, specifically the wind-heat syndrome. The formulation is designed to clear heat and detoxify the body. It has been evaluated in clinical trials, such as ChiCTR2200055642, which was a randomized, double-blind, parallel-controlled, multi-center trial for Chinese medicine variety protection. This trial compared the Niuhuang Qinggan Capsule to the Shufeng Jiedu Capsule to assess its efficacy and safety in patients with the common cold. The development and clinical evaluation of this drug have been sponsored by institutions such as The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niuhuang qinggan.